Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo.

We show that TNFi target multiple immune cell pathways that cooperate to resolve inflammation. We propose that immune response profiling provides new insight into the biology of TNF-blocker action in patients and can identify signalling pathways associated with therapeutic responses to biological therapies.